<DOC>
	<DOCNO>NCT00233909</DOCNO>
	<brief_summary>Chemotherapy drug use different way stop cancer cell divide stop grow die . Zosuquidar may help Gemtuzumab Ozogamicin ( GO ) kill cancer cell make cancer cell sensitive drug . It know whether Gemtuzumab Ozogamicin ( GO ) effective without zosuquidar treat acute myeloid leukemia .</brief_summary>
	<brief_title>A Trial Gemtuzumab Ozogamicin ( GO ) Combination With Zosuquidar Patients With CD33 Positive Acute Myeloid Leukemia</brief_title>
	<detailed_description>Purpose : Phase I : Determine optimal dose schedule GO zosuquidar use combination . Phase II : Determine complete remission rate ( CR+CRp )</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Gemtuzumab</mesh_term>
	<criteria>1 . Morphologic evidence acute myeloid leukemia first relapse . 2 . Phase I : 18 year old , Phase II : 50 year old 1 . Prior treatment zosuquidar 2 . Any investigational agent within 1 month enrollment lack recovery toxicity secondary agent 3 . History stem cell transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Leukemia , Myeloid</keyword>
	<keyword>Relapse</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Zosuquidar</keyword>
	<keyword>gemtuzumab ozogamicin ( GO )</keyword>
</DOC>